ammonium ferrous sulfate

synuclein alpha ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32104855 Iron-mediated interaction of alpha synuclein with lipid raft model membranes. 2020 Apr 14 1
2 33096655 Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules. 2020 Oct 21 2
3 29762502 Molecular Mechanisms of Apoptosis in HepaRG Cell Line Induced by Polyphyllin VI via the Fas Death Pathway and Mitochondrial-Dependent Pathway. 2018 May 15 1
4 28811225 Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL. 2017 Dec 1
5 21249223 Alpha-synuclein is a cellular ferrireductase. 2011 Jan 10 1
6 22860160 Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders. 2011 Nov 16 1
7 20005574 Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes. 2010 Apr 7
8 18211125 Abiotic reduction of nitroaromatic contaminants by iron(II) complexes with organothiol ligands. 2008 Jun 2
9 18592045 Studies on the Condensation Pathway to and Properties of Diiron Azadithiolate Carbonyls. 2007 2
10 16866548 Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. 2006 Aug 2 1
11 16984000 A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein. 2006 Jul 1
12 16087241 Metals accelerate the formation and direct the structure of amyloid fibrils of NAC. 2005 Sep 1
13 16246056 Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy. 2005 Nov 1
14 15180968 A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. 2004 Aug 1
15 14535945 Fe(II)-induced DNA damage in alpha-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assay. 2003 Nov 11
16 12031892 Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. 2002 Jun 1 1
17 10208537 Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. 1999 Mar 17 2